Skip to content

Why Subscribe
About Us
Accreditation
Library
Live Events
Sign Up / Login

Why Subscribe
About Us
Accreditation
Library
Live Events
Sign Up / Login

Library

By pinki shah / May 14, 2022

Speciality

Author / Speaker

Title of Presentation

Type of Media

Event

2024 Event

Clear

Displaying 326 - 350 of 2,573

«
1
…
12
13
14
15
16
…
103
»

HER-2 Disease - Neo-, Adjuvant,Metastatic Setting

HER-2 Disease - Neo-, Adjuvant,Metastatic Setting

By: Noridza Rivera-Rodriguez, MD

Use of CDK4/6 and PIK3CA Inhibitors in Breast Cancer

Use of CDK4/6 and PIK3CA Inhibitors in Breast Cancer

By: Noridza Rivera-Rodriguez, MD

Hormonal Therapy for Metastatic Breast Cancer

Hormonal Therapy for Metastatic Breast Cancer

By: Noridza Rivera-Rodriguez, MD

Guidelines for Hormone Therapy in Breast Cancer

Guidelines for Hormone Therapy in Breast Cancer

By: Noridza Rivera-Rodriguez, MD

Guidelines for Hormone Therapy in Breast Cancer

Guidelines for Hormone Therapy in Breast Cancer

By: Noridza Rivera-Rodriguez, MD

HER2-Driven Breast Cancer: Current Status and Next Generation Therapeutics

HER2-Driven Breast Cancer: Current Status and Next Generation Therapeutics

By: Otto Metzger, MD

Panel-Challenging Cases in Breast Cancer

Panel-Challenging Cases in Breast Cancer

By: Panel

Challenging Cases in Breast Cancer

Challenging Cases in Breast Cancer

By: Panel

From Bench to Bedside (and Back): Early Clinical Trials

From Bench to Bedside (and Back): Early Clinical Trials

By: Patricia LoRusso, DO, PhD

From Bench to Bedside & Back - Breast Cancer Management – Early Clinical Trials

From Bench to Bedside & Back - Breast Cancer Management – Early Clinical Trials

By: Patricia Mucci LoRusso, DO, PhD

HER2 Breast Cancer

HER2 Breast Cancer

By: Peter Kabos, MD

HER2 Breast Cancer

HER2 Breast Cancer

By: Peter Kabos, MD

HER2 Breast Cancer

HER2 Breast Cancer

By: Peter Kabos, MD

HER2 Breast Cancer

HER2 Breast Cancer

By: Peter Kabos, MD

Immunotherapy For Triple Negative Breast Cancer Optimal Chemotherapy Partners, New Directors, And Managing Toxicity

Immunotherapy For Triple Negative Breast Cancer Optimal Chemotherapy Partners, New Directors, And Managing Toxicity

By: Priyanka Sharma, MD

Endocrine Therapy for Advanced Breast Cancer: Current and Future Strategies

Endocrine Therapy for Advanced Breast Cancer: Current and Future Strategies

By: Reshma L. Mahtani, DO

Endocrine Therapy for Advanced Breast Cancer: Current and Future Strategies

Endocrine Therapy for Advanced Breast Cancer: Current and Future Strategies

By: Reshma L. Mahtani, DO

Challenges in Her-2 Breast Cancer

Challenges in Her-2 Breast Cancer

By: Reshma Mahtani, DO

Challenges in Her-2 Breast Cancer

Challenges in Her-2 Breast Cancer

By: Reshma Mahtani, DO

Breast Cancer Update in Hormone Sensitive Breast Cancer

Breast Cancer Update in Hormone Sensitive Breast Cancer

By: Ricardo H. Alvarez, MD

Breast Cancer Update in Hormone Sensitive Breast Cancer

Breast Cancer Update in Hormone Sensitive Breast Cancer

By: Ricardo H. Alvarez, MD

The Role of Immunotherapy in Breast Cancer

The Role of Immunotherapy in Breast Cancer

By: Richard S. Finn, MD

CDK4-6 and PIK3CA Inhibitors in Breast Cancer Management

CDK4-6 and PIK3CA Inhibitors in Breast Cancer Management

By: Richard S. Finn, MD

Updates in Metastatic Breast Cancer: Top News

Updates in Metastatic Breast Cancer: Top News

By: Sandra Franco, MD

Updates in Metastatic Breast Cancer: Top News

Updates in Metastatic Breast Cancer: Top News

By: Sandra Franco, MD

«
1
…
12
13
14
15
16
…
103
»

Post navigation

← Previous View

© 2024 MEC Inc. All rights reserved | Digital Marketing by Katapult Marketing

We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.Ok